FeesSafety
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Edgewise Therapeutics Inc. Common Stock (EWTX) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Dimensional Fund Advisors discloses 1.27% stake in Prologis Inc as of Nov 3, 2026

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc as of November 3, 2026. This disclosure is part of regulatory requirements under the Takeover Code for investors holding 1% or more in relevan...

Market News
1 hour ago
Na
Neutral
Dimensional Fund Advisors discloses 1.27% stake in Prologis Inc as of Nov 3, 2026

Dimensional Fund Advisors discloses 1.78% stake in DCC Energy shares as of Nov 2026

Dimensional Fund Advisors Ltd. has disclosed an interest in 1,516,595 ordinary shares of DCC Energy plc, representing 1.78% of the company's shares as of November 3, 2026. The disclosure follows regulatory requirements under the Irish Takeover Panel ...

Market News
1 hour ago
Na
Neutral
Dimensional Fund Advisors discloses 1.78% stake in DCC Energy shares as of Nov 2026

CrowdStrike launches AI Kill Switch, praised by Jim Cramer as a key AI safety breakthrough.

CrowdStrike introduced an AI Kill Switch in its Falcon Guardian product, allowing security teams to shut down rogue AI agents, a feature highlighted by Jim Cramer as a major advancement in AI safety. Currently, the Kill Switch works at the network ga...

Market News
5 hours ago
24/7 Wall Street
Bullish
news icon
CrowdStrike launches AI Kill Switch, praised by Jim Cramer as a key AI safety breakthrough.

Investigation launched into Cardinal Infrastructure for alleged securities fraud after 36% stock plunge.

Bleichmar Fonti & Auld LLP is investigating Cardinal Infrastructure Group for possible securities fraud related to misleading statements about the performance of its acquisition, A.L. Grading Contractors. The investigation follows a sharp 36% drop in...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Investigation launched into Cardinal Infrastructure for alleged securities fraud after 36% stock plunge.

Investigation launched into $212/share Penske Automotive privatization deal for shareholder fairness.

Bleichmar Fonti & Auld LLP is investigating the $212 per share merger where Roger Penske and Mitsui & Co. plan to take Penske Automotive Group private. The probe focuses on whether the deal terms, including the share price, comply with Delaware law a...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Investigation launched into $212/share Penske Automotive privatization deal for shareholder fairness.

Lululemon faces securities fraud probe after major stock drops linked to growth concerns.

Lululemon is under investigation by Bleichmar Fonti & Auld LLP for potential securities fraud following significant stock declines tied to concerns about its growth and business health. Key stock drops occurred after announcements of a new CEO, disap...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Lululemon faces securities fraud probe after major stock drops linked to growth concerns.

Law firm investigates Personalis merger at $16.25/share over potential fiduciary breaches.

Bleichmar Fonti & Auld LLP is investigating the $16.25 per share merger where Tempus AI is taking Personalis private. The probe focuses on whether the merger terms comply with Delaware law, considering Tempus AI's prior 12.5% stake and commercial tie...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Law firm investigates Personalis merger at $16.25/share over potential fiduciary breaches.

Medline faces securities fraud probe after FDA cites manufacturing issues and stock drops.

Medline Inc. is under investigation for potential securities fraud after the FDA issued a warning about significant manufacturing violations. The company's stock fell 7% in June and 13% in August following disclosures of quality issues and earnings l...

Market News
5 hours ago
GlobeNewsWire
Bearish
news icon
Medline faces securities fraud probe after FDA cites manufacturing issues and stock drops.

Enerpac unveils PROPEL growth strategy and sets fiscal 2030 targets at 2026 Investor Day

Enerpac Tool Group held its 2026 Investor Day at the New York Stock Exchange, introducing its new PROPEL strategy aimed at accelerating profitable growth and expanding market leadership. The company also announced financial targets for fiscal year 20...

Market News
5 hours ago
GlobeNewsWire
Bullish
news icon
Enerpac unveils PROPEL growth strategy and sets fiscal 2030 targets at 2026 Investor Day

IDEXX Labs beats Q3 expectations with strong revenue growth and raises full-year guidance.

IDEXX Laboratories reported strong Q3 results with 9.86% organic revenue growth, 13.4% operating income growth, and 17.9% EPS growth, exceeding market expectations. The company raised its full-year revenue and EPS guidance, driven by its best-in-clas...

Company Fundamentals
5 hours ago
Seeking Alpha
Bullish
news icon
IDEXX Labs beats Q3 expectations with strong revenue growth and raises full-year guidance.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $4.09B
  • Volume
    1,859,204
  • Sector
    Health
  • 52W High
    $48.35
  • 52W Low
    $17.09
  • Typical Hold Time
    17 Days
  • Enterprise Value
    $3.64B
  • Div Yield
    -
  • Trading Activity
    -
$37
52W Low: $17.09
06 Nov 2025
52W High: $48.35
09 Jul 2026

Track Edgewise Therapeutics Inc. Common Stock (EWTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Edgewise Therapeutics Inc. Common Stock has traded between a low of $17.09 and a high of $48.35, highlighting its annual price range. Buy and sell Edgewise Therapeutics Inc. Common Stock shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!